Overview
SCIENTIFIC SCORE
Moderately Effective
Based on 7 Researches
8
USERS' SCORE
Moderately Good
Based on 3 Reviews
7.9
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Lactobacillus acidophilus (La-14)
2 Billion CFU
*
Top Medical Research Studies
9
We explored the potential of Lactobacillus acidophilus KBL409 in addressing atopic dermatitis, a common form of eczema. By using a mouse model induced by house dust mites, we found that administering this probiotic led to significantly lower dermatitis scores and less immune cell infiltration in the skin.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Read More
9
We conducted a thorough investigation on the effects of Lactobacillus acidophilus L-92 in adults with atopic dermatitis.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
Read More
8
We evaluated the effects of L-92—a paraprobiotic—on young children suffering from atopic dermatitis (AD) and food allergies. In a study of 59 children aged 10 months to 3 years, participants were given either L-92 or a placebo alongside standard AD treatment over 24 weeks.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
Read More
Most Useful Reviews
9
Eczema relief
2 people found this helpful
For biotin therapy for hand eczema, I began taking it six months ago, alongside time-release vitamin C. I haven’t had eczema since and no longer need dermatological visits. Previously, I used cream and steroids. This treatment is affordable, and I recommend it to housewives and hairdressers who frequently work with water. However, I didn’t notice any effect on constipation.
Read More
7.5
Eczema improvement
2 people found this helpful
I started taking this for my hand eczema and found the small capsules easy to swallow. After a few months, I’ve noticed a reduction in my eczema. I’m considering trying the 3 billion dose next time.
Read More
0
Eczema caused by allergy
I purchased this to combat candida while managing my casein allergy, but it exacerbated my eczema. Unfortunately, it didn’t work for me.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 7 Researches
8
- All Researches
9
We explored the potential of Lactobacillus acidophilus KBL409 in addressing atopic dermatitis, a common form of eczema. By using a mouse model induced by house dust mites, we found that administering this probiotic led to significantly lower dermatitis scores and less immune cell infiltration in the skin.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Read More
9
We conducted a thorough investigation on the effects of Lactobacillus acidophilus L-92 in adults with atopic dermatitis.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
Read More
8
We evaluated the effects of L-92—a paraprobiotic—on young children suffering from atopic dermatitis (AD) and food allergies. In a study of 59 children aged 10 months to 3 years, participants were given either L-92 or a placebo alongside standard AD treatment over 24 weeks.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
Read More
8
This study aimed to find out if probiotics given to pregnant women could prevent allergic diseases in their children, particularly atopic dermatitis (AD).
In a randomized, double-blind trial, pregnant women consumed probiotic milk or placebo from 36 weeks gestation to three months postpartum.
We observed that probiotics significantly reduced the incidence of AD by half in infants compared to the placebo group. However, there was no impact on atopic sensitization or other allergies.
In a randomized, double-blind trial, pregnant women consumed probiotic milk or placebo from 36 weeks gestation to three months postpartum.
We observed that probiotics significantly reduced the incidence of AD by half in infants compared to the placebo group. However, there was no impact on atopic sensitization or other allergies.
Read More
We explored the potential of probiotics in preventing eczema in infants at high risk. In a robust double-blind, placebo-controlled trial involving 112 pregnant women, we observed that those who took a specific probiotic mix—including Lactobacillus acidophilus—had infants with a significantly lower prevalence of eczema compared to the placebo group.
Notably, the probiotic group had an eczema incidence of just 18.2% versus 40.0% in the placebo. However, we found no significant differences in allergy sensitization or overall IgE levels between the groups. This study suggests that the right probiotics may help prevent eczema in vulnerable infants.
Notably, the probiotic group had an eczema incidence of just 18.2% versus 40.0% in the placebo. However, we found no significant differences in allergy sensitization or overall IgE levels between the groups. This study suggests that the right probiotics may help prevent eczema in vulnerable infants.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 3 Reviews
7.9
- All Reviews
- Positive Reviews
- Negative Reviews
9
Eczema relief
2 people found this helpful
For biotin therapy for hand eczema, I began taking it six months ago, alongside time-release vitamin C. I haven’t had eczema since and no longer need dermatological visits. Previously, I used cream and steroids. This treatment is affordable, and I recommend it to housewives and hairdressers who frequently work with water. However, I didn’t notice any effect on constipation.
Read More
7.5
Eczema improvement
2 people found this helpful
I started taking this for my hand eczema and found the small capsules easy to swallow. After a few months, I’ve noticed a reduction in my eczema. I’m considering trying the 3 billion dose next time.
Read More
0
Eczema caused by allergy
I purchased this to combat candida while managing my casein allergy, but it exacerbated my eczema. Unfortunately, it didn’t work for me.
Read More
Frequently Asked Questions
9
Eczema relief
2 people found this helpful
For biotin therapy for hand eczema, I began taking it six months ago, alongside time-release vitamin C. I haven’t had eczema since and no longer need dermatological visits. Previously, I used cream and steroids. This treatment is affordable, and I recommend it to housewives and hairdressers who frequently work with water. However, I didn’t notice any effect on constipation.
7.5
Eczema improvement
2 people found this helpful
I started taking this for my hand eczema and found the small capsules easy to swallow. After a few months, I’ve noticed a reduction in my eczema. I’m considering trying the 3 billion dose next time.
0
Eczema caused by allergy
I purchased this to combat candida while managing my casein allergy, but it exacerbated my eczema. Unfortunately, it didn’t work for me.
9
We explored the potential of Lactobacillus acidophilus KBL409 in addressing atopic dermatitis, a common form of eczema. By using a mouse model induced by house dust mites, we found that administering this probiotic led to significantly lower dermatitis scores and less immune cell infiltration in the skin.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
7
We assessed how effective nutritional supplements, including probiotics like lactobacillus acidophilus, are for managing eczema symptoms.
Our analysis revealed weak evidence overall for any one supplement, though some, especially probiotics, showed potential benefits.
Specifically, lactobacillus acidophilus is linked to positive outcomes in several studies.
However, we found that larger trials are necessary for a clearer understanding of these supplements' impact on eczema across a wider population.
Our analysis revealed weak evidence overall for any one supplement, though some, especially probiotics, showed potential benefits.
Specifically, lactobacillus acidophilus is linked to positive outcomes in several studies.
However, we found that larger trials are necessary for a clearer understanding of these supplements' impact on eczema across a wider population.
8
We evaluated the effects of L-92—a paraprobiotic—on young children suffering from atopic dermatitis (AD) and food allergies. In a study of 59 children aged 10 months to 3 years, participants were given either L-92 or a placebo alongside standard AD treatment over 24 weeks.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
9
We conducted a thorough investigation on the effects of Lactobacillus acidophilus L-92 in adults with atopic dermatitis.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
We explored the potential of probiotics in preventing eczema in infants at high risk. In a robust double-blind, placebo-controlled trial involving 112 pregnant women, we observed that those who took a specific probiotic mix—including Lactobacillus acidophilus—had infants with a significantly lower prevalence of eczema compared to the placebo group.
Notably, the probiotic group had an eczema incidence of just 18.2% versus 40.0% in the placebo. However, we found no significant differences in allergy sensitization or overall IgE levels between the groups. This study suggests that the right probiotics may help prevent eczema in vulnerable infants.
Notably, the probiotic group had an eczema incidence of just 18.2% versus 40.0% in the placebo. However, we found no significant differences in allergy sensitization or overall IgE levels between the groups. This study suggests that the right probiotics may help prevent eczema in vulnerable infants.
References
- Kim WK, Jang YJ, Park S, Min SG, Kwon H, et al. Lactobacillus acidophilus KBL409 Ameliorates Atopic Dermatitis in a Mouse Model. J Microbiol. 2024;62:91. doi:10.1007/s12275-024-00104-5
- Weber I, Woolhiser E, Keime N, Wasvary M, Adelman MJ, et al. Clinical Efficacy of Nutritional Supplements in Atopic Dermatitis: Systematic Review. JMIR Dermatol. 2023;6:e40857. doi:10.2196/40857
- Nakata J, Hirota T, Umemura H, Nakagawa T, Kando N, et al. Additive effect of L-92 on children with atopic dermatitis concomitant with food allergy. Asia Pac Allergy. 2019;9:e18. doi:10.5415/apallergy.2019.9.e18
- Gulliver WP, Hutton AS, Ship N. Investigating the therapeutic potential of a probiotic in a clinical population with chronic hand dermatitis. Clin Cosmet Investig Dermatol. 2018;11:265. doi:10.2147/CCID.S164748
- Yamamoto K, Yokoyama K, Matsukawa T, Kato S, Kato S, et al. Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis. J Dairy Sci. 2016;99:5039. doi:10.3168/jds.2015-10605
- Dotterud CK, Storrø O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 2010;163:616. doi:10.1111/j.1365-2133.2010.09889.x
- Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21:e386. doi:10.1111/j.1399-3038.2009.00958.x
